A recent study using human squamous carcinoma cell lines has shown that luteolin ameliorates cancer metastasis by reducing the expression and activity of ribosomal protein S19 and inhibiting the AKT/mTOR/c-Myc signaling pathway [41]. The gene discussed is MTOR; the disease is cancer.